Clinical Trials Insight: 700021180
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2007
At a glance
- Drugs Teverelix (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Pharmacokinetics
- Sponsors Ardana plc
- 27 Feb 2007 Interim results have been reported.
- 27 Feb 2007 New trial record.